VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Other definitive proxy statements
Current report
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Nothing left to load.